CTLA4 and vitiligo: For example, irradiated B16 tumor cells producing GM-CSF (GVAX) combined with a blocking monoclonal antibody to CTLA-4 breaks tolerance to melanocyte differentation antigens, resulting in protective anti-tumor immunity and vitiligo [59].